Does blood donation affect HbA1c results? Yes — donating whole blood can cause a falsely low HbA1c reading, which may have significant implications for diabetes diagnosis and management. When you donate blood, your body produces new, younger red blood cells that have had less time to accumulate glycated haemoglobin, effectively diluting the HbA1c percentage. This article explains the mechanism behind this interference, how long the effect may last, what UK clinical guidance advises, and how to ensure your diabetes monitoring remains accurate if you are a regular blood donor.

How HbA1c Is Measured and What Affects Its Accuracy

HbA1c measures the proportion of haemoglobin with glucose attached, reflecting average blood glucose over approximately 120 days; accuracy is affected by conditions altering red blood cell lifespan, including anaemia, haemoglobinopathies, and blood donation.

HbA1c — glycated haemoglobin — is a blood test used to assess average blood glucose levels over the preceding two to three months. It works by measuring the proportion of haemoglobin molecules in red blood cells that have glucose permanently attached to them. Because red blood cells have a lifespan of approximately 120 days, the HbA1c result reflects a rolling average of blood sugar control rather than a single snapshot, making it a cornerstone of diabetes diagnosis and long-term management under NICE guidelines (NICE NG28).

Several physiological and clinical factors can influence HbA1c accuracy, and it is important for both patients and clinicians to be aware of these when interpreting results. Conditions that affect red blood cell turnover — such as haemolytic anaemia, iron deficiency anaemia, haemoglobinopathies (including sickle cell disease and thalassaemia), and chronic kidney disease — are well-recognised causes of falsely low or falsely high readings. It is worth noting that interference from haemoglobin variants (such as HbS or HbC) is assay-dependent; most UK laboratories use methods validated for common variants and will advise on the reliability of a result in affected individuals (RCPath/ACB guidance).

Regarding the directional effects of specific factors: iron deficiency can raise HbA1c independently of blood glucose, whilst iron supplementation and erythropoietin (EPO) therapy — by stimulating new red blood cell production — can lower HbA1c independently of glycaemic control. Pregnancy increases red cell turnover and can affect results; importantly, HbA1c should not be used to diagnose gestational diabetes, for which glucose-based tests are required per NICE NG3.

Key factors known to affect HbA1c accuracy include:

• Red blood cell lifespan (shorter lifespan = lower HbA1c)

• Haemoglobin variants (interference is assay-dependent; the laboratory will advise)

• Recent blood transfusion or significant blood loss

• Pregnancy (increased red cell turnover; HbA1c not used to diagnose gestational diabetes)

• Iron deficiency (can raise HbA1c) or iron/EPO treatment (can lower HbA1c)

Understanding these variables is essential because an inaccurate HbA1c result could lead to inappropriate clinical decisions — either missing a diagnosis of diabetes or incorrectly suggesting poor glycaemic control. Blood donation is one such variable that is increasingly recognised as clinically relevant.

Why Blood Donation Can Lower HbA1c Readings

Whole-blood donation causes a falsely low HbA1c by flooding the circulation with younger, less-glycated red blood cells, diluting the glycated haemoglobin percentage without any genuine improvement in blood glucose control.

When a person donates whole blood, they typically give around 450–500 ml in a single donation. This acute loss of red blood cells triggers the body to produce new red blood cells — a process called erythropoiesis — to restore circulating blood volume and oxygen-carrying capacity. These newly produced red blood cells are younger and have had less time to accumulate glycated haemoglobin, even if blood glucose levels have been consistently elevated.

Because HbA1c is expressed as a percentage of total haemoglobin, a sudden influx of younger, less-glycated red blood cells effectively dilutes the proportion of glycated haemoglobin in the sample. The result is a falsely low HbA1c reading — one that does not accurately reflect the individual's true average blood glucose over the preceding months. This is not a reflection of improved diabetes control; it is a mathematical consequence of altered red blood cell age distribution.

This mechanism is supported by clinical evidence, including observational studies published in journals such as Diabetic Medicine and the British Journal of Haematology, which have demonstrated that regular blood donors can have HbA1c values meaningfully lower than their actual glycaemic status would suggest. The magnitude of the effect varies between individuals and depends on timing relative to donation and donation frequency. In practical terms:

• A person with well-controlled type 2 diabetes who donates blood may appear to have an even lower HbA1c than expected

• A person with undiagnosed or poorly controlled diabetes may receive a falsely reassuring result

• The degree of reduction depends on the timing of donation relative to testing and the frequency of donations

It is important to distinguish whole-blood donation from apheresis procedures (such as platelet or plasma donation). In apheresis, red blood cells are separated out and returned to the donor; only the target component is retained. As a result, platelet and plasma apheresis donations typically have minimal impact on HbA1c, because the red cell population is not substantially reduced. This article focuses primarily on whole-blood donation, which is the most common form of donation in the UK.

How Long the Effect on HbA1c Results May Last

The effect of a single whole-blood donation on HbA1c is greatest in the weeks immediately after donation and typically diminishes over eight to twelve weeks, though some sources suggest unreliability for up to three months.

The duration of the effect on HbA1c results depends on how quickly the body replenishes its red blood cell population following donation. After a whole-blood donation, the bone marrow responds by increasing red blood cell production. However, full restoration of the normal red blood cell age distribution — where cells range from newly produced to approximately 120 days old — takes time.

Based on red blood cell lifespan and observational data, the impact of a single whole-blood donation on HbA1c is considered most significant in the weeks immediately following donation, with the effect gradually diminishing over approximately eight to twelve weeks. This interval is a pragmatic estimate reflecting expert consensus and laboratory practice rather than a formally mandated NHS or NICE guideline; it should be treated as a guide rather than a fixed rule. Some clinical sources suggest that HbA1c results may remain unreliable for up to three months after donation, corresponding to the full lifespan of a red blood cell.

Recovery speed can also vary between individuals. Factors such as iron deficiency, baseline anaemia, or EPO use may slow the restoration of a normal red cell age distribution and prolong the period during which HbA1c is unreliable. If a clinical decision cannot wait for this interval — for example, if diabetes diagnosis is being considered — glucose-based tests (fasting plasma glucose, oral glucose tolerance test, or random plasma glucose with symptoms) should be used in preference to HbA1c, in line with NICE NG28.

For regular or frequent donors — those who give blood every 12 to 16 weeks, as permitted by NHS Blood and Transplant (NHSBT) — the effect may be more persistent. If donations are timed such that a new donation occurs before the red blood cell population has fully recovered from the previous one, HbA1c may be chronically underestimated. This is particularly relevant for:

• Frequent whole-blood donors (donating at or near the minimum permitted interval)

• Individuals undergoing HbA1c monitoring for diabetes diagnosis or treatment review

• Note: platelet and plasma apheresis donors are generally not affected in the same way, as red cells are returned during the procedure

Clinicians should always ask patients about recent blood donation when reviewing HbA1c results, particularly if the result appears unexpectedly low or inconsistent with other clinical findings.

What NHS Guidelines Say About HbA1c Testing After Donation

No formal NICE or NHS directive mandates a specific waiting period, but clinical best practice recommends waiting approximately eight to twelve weeks after whole-blood donation and using glucose-based tests if a diagnostic decision cannot be delayed.

At present, there is no specific NICE guideline or NHS-wide protocol that formally mandates a defined waiting period between blood donation and HbA1c testing. However, the clinical evidence supporting the interference of whole-blood donation with HbA1c accuracy is well-established, and this is recognised as a pre-analytical source of error by UK laboratory bodies including the Royal College of Pathologists (RCPath) and the Association for Clinical Biochemistry and Laboratory Medicine (ACB).

NHS Blood and Transplant (NHSBT) provides guidance to donors about the physiological effects of donation. Some NHS diabetes services advise patients to inform their GP or diabetes team if they have recently donated blood before an HbA1c test is due. Diabetes UK highlights the importance of considering red blood cell turnover when interpreting HbA1c, particularly in populations where donation is common.

In the absence of a universal waiting period directive, clinical best practice — based on red cell lifespan and laboratory guidance — generally suggests:

• Waiting approximately eight to twelve weeks after a whole-blood donation before relying on an HbA1c result for clinical decision-making (this is pragmatic expert consensus, not a formal NICE or NHS directive)

• Documenting recent donation in the patient's medical record so that results can be interpreted in context

• Using glucose-based diagnostic tests (fasting plasma glucose, oral glucose tolerance test, or random plasma glucose with symptoms) when HbA1c is known to be unreliable and a diagnostic decision is required, in line with NICE NG28

• Considering fructosamine testing as an adjunct for monitoring average glucose over the preceding two to three weeks in situations where HbA1c is unreliable — noting that fructosamine is not a NICE-recommended diagnostic test and can itself be affected by conditions altering albumin or protein levels (such as liver disease or nephrotic syndrome)

• Continuous glucose monitoring (CGM), where clinically indicated and commissioned, can provide detailed glycaemic data independent of HbA1c

Patients should not feel discouraged from donating blood; rather, the timing of routine diabetes blood tests should be planned thoughtfully in relation to donation schedules. Open communication between the patient and their healthcare team is key to ensuring accurate monitoring.

When to Rearrange Your HbA1c Test as a Blood Donor

Rescheduling is most important if you have donated whole blood within the past eight to twelve weeks, particularly if the test is for diabetes diagnosis or treatment review; platelet and plasma apheresis donors are generally unaffected.

If you are a blood donor and have an HbA1c test scheduled — whether for routine diabetes monitoring, a diabetes review, or as part of a health check — it is worth considering the timing carefully. As a general principle, if you have donated whole blood within the past eight to twelve weeks, it may be advisable to discuss rescheduling your HbA1c test with your GP or diabetes nurse to ensure the result is as accurate as possible. If you donate platelets or plasma via apheresis, this is unlikely to have a meaningful effect on your HbA1c, as your red blood cells are returned to you during the procedure.

Rescheduling is especially important in the following situations:

• You are being tested for the first time to diagnose or rule out diabetes — a falsely low result could delay a necessary diagnosis; in this situation, your GP may recommend a glucose-based test instead

• Your diabetes treatment is being reviewed or adjusted based on HbA1c — an inaccurate result could lead to inappropriate changes in medication

• Your HbA1c result appears unexpectedly low compared to previous readings or your home blood glucose monitoring

• You donate blood frequently and your HbA1c has been consistently lower than expected

Conversely, if your HbA1c test is due and your next planned donation is imminent, it may be worth having the blood test first and then donating afterwards, provided this fits within your clinical review schedule. Always discuss any changes to your monitoring plan with your GP surgery or diabetes team, and follow local laboratory advice where available.

Regarding eligibility to donate: NHSBT permits donation from individuals with diet- or tablet-controlled diabetes in most circumstances. However, people who use insulin to manage their diabetes are generally not eligible to donate blood under current NHSBT criteria. If you are unsure whether you are eligible to donate, contact NHSBT directly. The concern discussed in this article is purely about the accuracy of subsequent laboratory testing, not about the safety of donation itself.

Talking to Your GP About Accurate Diabetes Monitoring

Informing your GP of your donation history — including date and frequency — allows results to be interpreted correctly; if HbA1c is unreliable, NICE NG28 supports glucose-based testing as an alternative diagnostic approach.

Open and proactive communication with your GP or diabetes care team is the most effective way to ensure your HbA1c results are interpreted correctly in the context of blood donation. Many patients are unaware that donation can affect their results, and equally, some clinicians may not routinely ask about donation history when reviewing blood tests. Raising this yourself can make a meaningful difference to the quality of your care.

When attending a diabetes review or requesting an HbA1c test, it is helpful to mention:

• The date of your most recent blood donation

• How frequently you donate (e.g., every 12 weeks, every 16 weeks)

• Whether your HbA1c results have seemed inconsistently low compared to your home glucose readings or symptoms

Your GP may recommend waiting before repeating the test, or they may consider alternative methods of assessing glycaemic control. If a diagnostic decision is needed and HbA1c is unreliable, NICE NG28 recommends using plasma glucose-based tests — such as a fasting plasma glucose, oral glucose tolerance test (OGTT), or random plasma glucose in the presence of symptoms. Fructosamine is an alternative monitoring tool that reflects average blood glucose over the preceding two to three weeks and is not affected by red blood cell lifespan; however, it can be influenced by conditions that alter protein or albumin levels (such as liver disease or nephrotic syndrome), and it is not a NICE-recommended diagnostic test. Continuous glucose monitoring (CGM) and flash glucose monitoring devices can also provide detailed glycaemic data independent of HbA1c; access on the NHS is subject to NICE criteria and local commissioning policies, and is most established for people with type 1 diabetes and certain people with type 2 diabetes on insulin.

If you experience symptoms that may suggest your blood glucose is poorly controlled — such as increased thirst, frequent urination, unexplained fatigue, or blurred vision — contact your GP promptly rather than waiting for your next scheduled review. If you develop symptoms that could indicate diabetic ketoacidosis (DKA) — including abdominal pain, vomiting, drowsiness, deep or rapid breathing, confusion, or the smell of ketones on the breath — seek urgent same-day medical assessment or call 999 in an emergency. Accurate monitoring is fundamental to preventing long-term diabetes complications, and ensuring your test results reflect your true glycaemic status is an important part of that process.

Not sure if this is normal? Chat with one of our pharmacists →

If you believe a medicine you are taking may be affecting your blood glucose or test results, you can report this to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions